Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Systematic Error: Methodological and Sampling Errors01:15

Systematic Error: Methodological and Sampling Errors

In the case of systematic errors, the sources can be identified, and the errors can be subsequently minimized by addressing these sources. According to the source, systematic errors can be divided into sampling, instrumental, methodological, and personal errors.
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tutorial on monitoring time to next medication error.

Quality management in health care·2007
Same author

Ethical dilemmas among nurses as they transition to hospital case management: implications for organizational ethics, part II.

Professional case management·2007
Same author

Ethical dilemmas among nurses as they transition to hospital case management: implications for organizational ethics, part I.

Professional case management·2007
Same author

Disability care coordination organizations: improving health and function in people with disabilities.

Lippincott's case management : managing the process of patient care·2006

Related Experiment Videos

Probabilistic risk analysis of medication error.

Cynthia Hovor1, Lolita T O'Donnell

  • 1Department of Health Administration and Policy, George Mason University, Fairfax, Virginia 22030, USA.

Quality Management in Health Care
|December 1, 2007
PubMed
Summary
This summary is machine-generated.

This study applies Bayesian Causal Network Models to analyze medication errors, identifying behavioral and systemic factors. This helps healthcare professionals proactively reduce risks and improve patient safety.

Related Experiment Videos

Area of Science:

  • Health Services Research
  • Medical Informatics
  • Risk Management

Background:

  • The United States invests heavily in healthcare quality and safety through new drugs and technologies.
  • Medication errors pose a significant threat to patient safety and healthcare quality.
  • Probabilistic risk analysis is crucial for understanding and mitigating rare adverse events.

Purpose of the Study:

  • To demonstrate the application of Bayesian Causal Network Models for assessing medication error probabilities.
  • To identify behavioral and systemic factors contributing to medication errors.
  • To provide a tool for prospective risk reduction in healthcare settings.

Main Methods:

  • Utilized a probabilistic risk analysis framework.
  • Applied Bayesian Causal Network Models to analyze medication error processes.
  • Employed importance sampling on incident reports from a community hospital to improve rare event estimations.

Main Results:

  • The Bayesian Causal Network Model generated contextual maps of factors leading to medication delivery failures.
  • Identified unanticipated risks, near misses, and deviations from standard procedures.
  • Demonstrated the model's capability to map causes within reported medication events.

Conclusions:

  • The Bayesian Causal Network Model effectively identifies behavioral and systemic factors influencing medication errors.
  • Enables healthcare administrators, clinicians, and regulators to prospectively prioritize risk reduction interventions.
  • Enhances the identification and mitigation of specific errors like wrong drug, dose, frequency, or patient.